Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 47

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 21, 2014; 20(47): 17976-17984
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17976

Table 2 Utility data for patients in adjuvant chemotherapy

Parameters	Value	Data source
Well state	0.84	Mehmet US Ayvaci and others, 2012
Minor toxicity state	0.73
Major toxicity state	0.59
Quitting adjuvant chemotherapy	0.47
Death due to adjuvant chemotherapy	0.00

Citation: Wen F, Yao K, Du ZD, He XF, Zhang PF, Tang RL, Li Q. Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World J Gastroenterol 2014; 20(47): 17976-17984
URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17976.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i47.17976

Wen F, Yao K, Du ZD, He XF, Zhang PF, Tang RL, Li Q. Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World J Gastroenterol 2014; 20(47): 17976-17984 [PMID: 25548497 DOI: 10.3748/wjg.v20.i47.17976]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.